3-BrPA	3-Bromopyruvate
5-AC	5-azacytidine
6-OHDA	6-hydroxydopamine
Aβ	Amyloid-β
AC	Adenocarcinomas
AD	Alzheimer’s diseases
ADKFM	Adenine diet kidney fibrosis model
ALD	Alcoholic liver disease
ALS	Amyotrophic lateral sclerosis
AKI	Acute kidney injury
AML	Acute myeloid leukemia
APOE	Apolipoprotein E
ARDS	Acute respiratory distress syndrome
BMDMs	Bone marrow-derived macrophages
CaMKII	Ca2+/calmodulin-dependent protein kinase II
Ch25h	Cholesterol 25-hydroxylase
cIAPs	Cellular inhibitor of apoptosis proteins
CKD	Chronic kidney disease
CLL	Chronic lymphocytic leukemia
CNLS	Ceramide nano-liposomes
COPD	Chronic obstructive pulmonary disease
CYLD	Cylindromatosis
CXCL1	C-X-C Motif Chemokine Ligand 1
DAC	5-aza-2’-deoxycytidine
DAI	DNA-dependent activator of IRFs
DAMPs	Damage-associated molecular patterns
DAPE	1,2-Diarachidonoyl-sn-glycero-3-phosphoethanolamine
DMA	Disease-associated microglia
DMF	Dimethyl fumarate
DRs	Death receptors
Drp1	Dynamin-related protein 1
EAE	Experimental allergic encephalomyelitis
FADD	Fas-associated protein with death domain
FA-AKI	Folic acid-induced AKI model
FAO	Fatty acid β-oxidation
FLIPL	FLICE-like inhibitory protein long form
Fn-14	Fibroblast growth factor-inducible 14
FTD	Frontotemporal dementia
Fer-1	Ferrostatin-1
GAT	Ganoderic acid T
GLUD1	Glutamate dehydrogenase 1
GSK	GlaxoSmithKline
HD	Huntington disease
HFFC	High in fat, fructose, and cholesterol
HFD	High-fat diet
HMGB1	High-mobility group box 1
HPβCD	2-hydroxypropyl-β-cyclodextrin
ICBs	Immune-checkpoint blockades
IFN-γ	Interferon-gamma
IPF	Idiopathic pulmonary fibrosis
I/R	Ischemia/reperfusion
MAPKs	Mitogen-activated protein kinases
MCAO	Middle cerebral artery occlusion
MCD	Methionine–choline-deficient
MLKL	Mixed-lineage kinase domain-like
MMS	Methyl methanesulfonate
MS	Multiple sclerosis
LAD	Left anterior descending coronary artery
LDL	Low-density lipoprotein
LOAD	Late-onset AD
LPS	Lipopolysaccharides
LRRK2	Leucine-rich repeat kinase 2
NAFLD	Non-alcoholic fatty liver disease
NASH	Non-alcoholic steatohepatitis
NBC1	Necroptosis-blocking compound 1
Nec-1	Necrostatin-1
NF-κβ	Nuclear factor kappa B
NEMO	NF-κB essential modulator
NOX4	NADPH Oxidase 4
NSA	Necrosulfonamide
NSCLC	Non-small cell lung cancer tissue
PAMPs	Pathogen-associated molecular patterns
PBPs	Protein-bound polysaccharides
PCD	Programmed cell death
PD	Parkinson’s disease
PDA	Pancreatic ductal adenocarcinomas
PGAM5	Phosphorylate phosphoglycerate mutase family member 5
PI3K/AKT	Phosphoinositide-3-kinase–protein kinase B/Akt
Poly I:C	Polyionisic:polycytidylic acid
PYCARD	PYD And CARD Domain Containing
RA	Rheumatoid arthritis
RGMB	Repulsive guidance molecule B
RHIM	RIP homotypic interaction motif
RIPK	Receptor-interacting protein kinase
RNI	Reactive-nitrogen intermediates
SHIP	Src homology 2 domain-containing inositolphosphate 5’-phosphatase
SIRS	Sepsis/systemic inflammatory associated disorder
SCC	Squamous cell carcinoma
SCI	Spinal cord neuronal injury
TAB	TAK1-binding protein
tGCI	Transient global cerebral ischemia
TNF	Tumor necrosis factor
TLRs	Toll-like receptors
TRADD	TNFR-associated death domain
TRAF	TNFR-associated factor
TWEAK	Tumor necrosis factor-related weak inducer of apoptosis
UUO	Unilateral ureteral obstruction
ZBP1	Z-DNA binding protein 1
Z-VAD-FMK	Carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]- fluoromethylketone